A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.

Source:http://linkedlifedata.com/resource/pubmed/id/9078354

Download in:

View as

General Info

PMID
9078354